Full-Life Technologies breaks ground for GMP manufacturing facility to advance its end-to-end solution for radiopharmaceuticals in Belgium, Europe.
The 4,000 square metre, state-of-the-art facility is designed as a production hub, seamlessly blending sustainable practises with automation and digital quality assurance systems.
Spanning 17,000 square metres, this facility is designed to cater to the production of a diverse range of radiopharmaceuticals, emphasising its specialised and comprehensive approach within the field.
It aims to enhance comprehensive solution by boosting its ability to manufacture radiopharmaceuticals at the logistical hub, ensuring timely global delivery to patients.
This facility will ensure a establish a consistent and dependable supply chain for clinical development. Additionally, it boasts a robust logistical network, further enhancing the efficiency and effectiveness of operations within the region.
At its core, the facility prioritises maintaining stringent control, reliability, and cost-effectiveness within its supply chain.
Name Full-Life Technologies
Type New Construction